Olema Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CNTA
Centessa Pharmaceuticals plc |
$16.74 | $884.24 M | -6.2 | 75 | $6.85 M |
DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
FENC
Fennec Pharmaceuticals Inc. |
$6.08 | $187.43 M | 171.5 | 29 | $21.25 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
IRON
Disc Medicine, Inc. |
$62.04 | $967.11 M | -11.82 | 84 | $0 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
OBIO
Orchestra BioMed Holdings, Inc. |
$5.66 | $285.59 M | -5.47 | 56 | $2.76 M |
PEPG
PepGen Inc. |
$3.68 | $537.15 M | -5.11 | 81 | $0 |
PHVS
Pharvaris N.V. |
$18.06 | $843.31 M | -5.8 | 92 | $0 |
SANA
Sana Biotechnology, Inc. |
$1.75 | $1.55 B | -4.59 | 328 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
